Immunization with analogue peptide in combination with CpG and Montanide expands tumor antigen-specific CD8+ T cells in melanoma patients

Analogue peptides represent a promising tool to further optimize peptide-based vaccines in promoting the expansion of tumor antigen-specific CTLs. Here, we report the results of a pilot trial designed to study the immunogenicity of the analogue peptide NY-ESO-1 157-165V in combination with CpG 7909/...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Fourcade, Julien, Kudela, Pavol, Filho, Pedro A. Andrade, Janjic, Bratislav, Land, Stephanie R., Sander, Cindy, Krieg, Arthur, Donnenberg, Albert, Shen, Hongmei, Kirkwood, John M., Zarour, Hassane M.
Format: Artigo
Langue:Inglês
Publié: 2008
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3901357/
https://ncbi.nlm.nih.gov/pubmed/18779741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0b013e318183af0b
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires